Loading...

IBIL's Increased Stake In Fraser And Neave Will Expand Future Market Reach

Published
25 Nov 24
Updated
01 May 25
AnalystConsensusTarget's Fair Value
S$0.61
22.6% undervalued intrinsic discount
04 Sep
S$0.47
Loading
1Y
-10.5%
7D
0%

Author's Valuation

S$0.6

22.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 8.02%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 1.49%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 1.52%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 5.71%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 1.41%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 14%

AnalystConsensusTarget has decreased revenue growth from 7.8% to 3.8%, increased future PE multiple from 12.8x to 15.9x and decreased shares outstanding growth rate from 0.0% to 0.0%.